A Shared Decision-Making Aid for Opioid Agonist Therapy in the Emergency Department
A new study details the development and preliminary evaluation of a conversation aid designed to facilitate shared decision-making for initiating methadone or buprenorphine treatment for opioid use disorder (OUD) in emergency department settings. Using community-based participatory research principles, the team, in partnership with people with lived experience, iteratively refined the “Talk About It” (TAI) tool. The research involved over 100 participants, including patients with untreated OUD and clinicians, to assess the aid’s acceptability, appropriateness, and feasibility. The final version received high scores from ED patients, indicating strong potential for implementation to address interpersonal and knowledge-related barriers to effective opioid agonist treatment.
Study Significance: For nephrology professionals managing patients with chronic kidney disease or end-stage renal disease, who are at high risk for both pain management challenges and potential drug-induced kidney injury, this tool represents a critical development. It provides a structured, patient-approved framework for discussing complex pharmacotherapies, which is directly applicable to navigating nephrotoxicity risks and medication safety in a vulnerable population. Implementing such shared decision-making protocols can enhance patient-centered care, improve adherence to safe prescribing guidelines, and mitigate the risks of contrast-induced nephropathy and other forms of acute kidney injury associated with certain analgesics and their alternatives.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
